tradingkey.logo

Biote Corp

BTMD
查看详细走势图
2.780USD
+0.030+1.09%
收盘 12/19, 16:00美东报价延迟15分钟
85.29M总市值
3.07市盈率 TTM

Biote Corp

2.780
+0.030+1.09%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.09%

5天

+2.96%

1月

+6.11%

6月

-29.80%

今年开始到现在

-55.02%

1年

-54.43%

查看详细走势图

TradingKey Biote Corp股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Biote Corp当前公司基本面数据相对健康,增长潜力较大。当前估值合理,在专业与商业服务行业排名83/156位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价5.09。中期看,股价处于平稳状态。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Biote Corp评分

相关信息

行业排名
83 / 156
全市场排名
218 / 4582
所属行业
专业与商业服务

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 5 位分析师
买入
评级
5.093
目标均价
+98.96%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Biote Corp亮点

亮点风险
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
业绩高增长
公司营业收入稳步增长,连续3年增长19.54%
估值合理
公司最新PE估值3.07,处于3年历史合理位
机构减仓
最新机构持股20.37M股,环比减少0.13%
PRFDX持仓
明星投资者PRFDX持仓,最新持仓市值2.54K
活跃度增加
近期活跃度增加,过去20天平均换手率0.51

Biote Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Biote Corp简介

biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
公司代码BTMD
公司Biote Corp
CEOChristensen (Bret)
网址https://haymakeracquisition.com/

常见问题

Biote Corp(BTMD)的当前股价是多少?

Biote Corp(BTMD)的当前股价是 2.780。

Biote Corp的股票代码是什么?

Biote Corp的股票代码是BTMD。

Biote Corp股票的52周最高点是多少?

Biote Corp股票的52周最高点是6.360。

Biote Corp股票的52周最低点是多少?

Biote Corp股票的52周最低点是2.315。

Biote Corp的市值是多少?

Biote Corp的市值是85.29M。

Biote Corp的净利润是多少?

Biote Corp的净利润为3.16M。

现在Biote Corp(BTMD)的股票是买入、持有还是卖出?

根据分析师评级,Biote Corp(BTMD)的总体评级为买入,目标价格为5.093。

Biote Corp(BTMD)股票的每股收益(EPS TTM)是多少

Biote Corp(BTMD)股票的每股收益(EPS TTM)是0.906。
KeyAI